{"id":"W2041657104","doi":"10.1161/01.cir.103.8.1044","title":"Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure","year":2001,"lang":"en","type":"article","venue":"Circulation","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":true,"ca_institutions":"Research & Development Corporation","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Etanercept; Medicine; Heart failure; Placebo; Ejection fraction; Tumor necrosis factor alpha; Internal medicine; Cardiology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688117,0.0004473078,0.001801109,0.000152402,0.0002750784,0.0004503435,0.0001675644,0.0006165825,0.001019562],"category_scores_gemma":[0.001794715,0.0001320468,0.0008704205,0.0001506346,0.0003164016,0.0004137523,0.0002010178,0.0007825989,0.0002101997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002695724,"about_ca_system_score_gemma":0.0002593971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002170455,"about_ca_topic_score_gemma":0.0002738477,"domain_scores_codex":[0.9992241,0.0004393923,0.00006954584,0.00009077981,0.00007742034,0.00009882222],"domain_scores_gemma":[0.9987767,0.0004487911,0.0002223321,0.00009268074,0.00007815942,0.0003813917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6078938,0.01547077,0.08647142,0.0008647825,0.00280751,0.001208053,0.000441346,0.002727027,0.02915499,0.0001431341,0.001621131,0.2511961],"study_design_scores_gemma":[0.1264954,0.4572313,0.3955801,0.0001576756,0.003148738,0.001991158,0.0001948957,0.001529987,0.008453834,0.000282845,0.004860822,0.00007319296],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940839,0.003826946,0.0002232228,0.0001917382,0.00004461281,0.0001316076,0.0001543055,0.00002043669,0.001323159],"genre_scores_gemma":[0.9984352,0.0004475665,0.0001889428,0.0002409378,0.00006148376,0.00007902249,0.0002216446,0.0000033151,0.0003217791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001801109,"threshold_uncertainty_score":0.008927763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01046002586202335,"score_gpt":0.2336407936437849,"score_spread":0.2231807677817615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}